MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $2,297,000 | +23.4% | 38,092 | -5.9% | 0.05% | +21.4% |
Q1 2016 | $1,862,000 | -4.9% | 40,500 | 0.0% | 0.04% | -10.6% |
Q4 2015 | $1,958,000 | +2.4% | 40,500 | -10.0% | 0.05% | -2.1% |
Q3 2015 | $1,913,000 | +52.7% | 45,000 | +115.3% | 0.05% | +108.7% |
Q3 2013 | $1,253,000 | – | 20,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |